ClinConnect ClinConnect Logo
Search / Trial NCT02809625

Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis

Launched by THE AFFILIATED HOSPITAL OF INNER MONGOLIA MEDICAL UNIVERSITY · Jun 18, 2016

Trial Information

Current as of May 29, 2025

Recruiting

Keywords

Dynamic Contrast Enhanced Mri Brucella Spondylitis

ClinConnect Summary

This clinical trial is studying a new way to help diagnose a condition called brucellar spondylitis, which is a type of infection that affects the spine and can lead to serious health problems if not treated early. The researchers are using a special imaging technique called DCE-MRI to look for signs of this condition in patients who have been exposed to the bacteria that cause brucellosis, a disease often linked to animals and dairy products. Early diagnosis is crucial because it can improve treatment outcomes and reduce the need for surgery.

To participate in this trial, individuals aged between 12 and 65 years old who show symptoms such as low fever, night sweats, and back pain may be eligible, provided they do not have other serious conditions like tuberculosis or cancer that affects the spine. Participants can expect to undergo imaging tests and possibly receive treatment as part of the study. This research could help doctors better identify brucellar spondylitis earlier, leading to improved care for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The epidemiological exposure history of different extents, accompanied with symptoms including
  • low fever
  • night sweats
  • intermittent lower back pain
  • movement limitation
  • Exclusion Criteria:
  • With other disease like tuberculous spondylitis,vertebral metastases,etc

About The Affiliated Hospital Of Inner Mongolia Medical University

The Affiliated Hospital of Inner Mongolia Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct rigorous studies aimed at improving patient outcomes and contributing to medical knowledge. With a commitment to ethical practices and collaboration, the hospital fosters partnerships with academic institutions and industry stakeholders, ensuring that its trials meet the highest standards of scientific integrity and patient safety.

Locations

Inner Mongolia, , China

Patients applied

0 patients applied

Trial Officials

Peng fei Qiao, MD

Study Director

The Affiliated Hospital of Inner Mongolia Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials